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Albinism is a genetic defect characterized by a loss of pigmentation. The neurosensory retina, which is not pigmented,
exhibits pathologic changes secondary to the loss of pigmentation in the retina pigment epithelium (RPE). How the loss
of pigmentation in the RPE causes developmental defects in the adjacent neurosensory retina has not been
determined, but offers a unique opportunity to investigate the interactions between these two important tissues. One
of the genes that causes albinism encodes for an orphan GPCR (OA1) expressed only in pigmented cells, including the
RPE. We investigated the function and signaling of OA1 in RPE and transfected cell lines. Our results indicate that OA1
is a selective L-DOPA receptor, with no measurable second messenger activity from two closely related compounds,
tyrosine and dopamine. Radiolabeled ligand binding confirmed that OA1 exhibited a single, saturable binding site for
L-DOPA. Dopamine competed with L-DOPA for the single OA1 binding site, suggesting it could function as an OA1
antagonist. OA1 response to L-DOPA was defined by several common measures of G-protein coupled receptor (GPCR)
activation, including influx of intracellular calcium and recruitment of b-arrestin. Further, inhibition of tyrosinase, the
enzyme that makes L-DOPA, resulted in decreased PEDF secretion by RPE. Further, stimulation of OA1 in RPE with L-
DOPA resulted in increased PEDF secretion. Taken together, our results illustrate an autocrine loop between OA1 and
tyrosinase linked through L-DOPA, and this loop includes the secretion of at least one very potent retinal neurotrophic
factor. OA1 is a selective L-DOPA receptor whose downstream effects govern spatial patterning of the developing
retina. Our results suggest that the retinal consequences of albinism caused by changes in melanin synthetic
machinery may be treated by L-DOPA supplementation.
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Introduction
Albinism is a group of inherited genetic diseases in which
there is a variable loss of pigmentation in the eye, hair, or
skin. When the eye is affected, there are signiﬁcant alterations
in neurosensory retina development that lead to low vision
[1–8]. There are two broad classes of albinism, ocular-
cutaneous albinism (OCA) and ocular albinism (OA). OCA
occurs when all pigmented tissues exhibit hypopigmentation
and involves genetic mutations that result in defects in the
melanin synthetic machinery [3,7–9]. OA occurs when
cutaneous tissues pigment normally, but the ocular tissues
are hypopigmented [10,11]. Since the same proteins produce
pigment in all tissues, OA most likely results from lack of
expression of the melanogenic enzymes in ocular tissue
rather than an inability to synthesize melanin, because the
other tissues pigment normally.
OA can be linked to at least one gene, Oa1, which is found
on the X chromosome. Oa1 encodes a 404–amino acid
protein likely to be an orphan G-protein coupled receptor
(GPCR), OA1 (GenBank GPR143) [12,13] based upon se-
quence analysis [14]. Schiafﬁno et al. have demonstrated that
OA1 associates with several Ga subunits as well as Gb, adding
further evidence that OA1 is a GPCR [14,15]. Indeed,
Innamorati et. al. used a combinatorial expression strategy
to illustrate GPCR-like activity from OA1, as well as b-arrestin
association, even in the absence of a ligand [16]. This work
suggested that OA1 could signal through a Gaq subunit
through phospholipase C and inositol triphosphate second
messengers. In a yeast-based expression system, Staleva and
Orlow have demonstrated GPCR signaling from OA1 that
appeared to be activated by a component in the melanosomal
compartment [17]. Despite the signiﬁcant amount of circum-
stantial evidence that OA1 is a GPCR, conﬁrmation is lacking
because no ligand has been identiﬁed. Other data have called
into question the idea that OA1 is a GPCR. For example, the
localization of OA1 as a fully intracellular protein is not
typical of GPCRs and suggests that it would be a unique
member of the family [14]. OA1 is primarily localized to the
endolysomal compartment [14,15,18–21] and melanosomes
[11,14,22] rather than the cell surface.
In this study, we investigated the function of OA1 as a
potential GPCR. Our hypothesis was that the endosomal
localization of OA1 in cultured cells was due to internal-
ization of OA1 in response to an agent in the culture
medium. Further, we sought a ligand for OA1 based on the
observation that all forms OCA and OA appear to have the
same retinal phenotype, indicating that tyrosinase activity
and OA1 signaling are coupled upstream of retinal develop-
ment. Thus, we tested whether tyrosinase activity produces
the ligand for OA1. A by-product of melanin synthesis is L-
DOPA, which is released to the retina during melanin
synthesis in the RPE at a critical time in retinal development
[23,24]. Our data suggest that OA1 is a highly selective L-
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PLoS BIOLOGYDOPA receptor, and that L-DOPA causes OA1 signaling with
the downstream effect of neurotrophic factor secretion by
RPE. Thus, we present the ﬁrst evidence of a ligand for OA1,
and provide a mechanism through which either tyrosinase or
OA1 deﬁciency results in changes to retinal development.
Results
Cell Surface Localization of OA1
OA1 has previously been localized in pigment granules in
situ [22]; however, using transfected cells of various types,
OA1 also has been localized to both the plasma membrane
[16,17] and the endosomal fraction of cultured cells [14,16–
18,20,21]. We began our investigation by determining where
OA1 resides in the human tissue, using cell surface
biotinylation/western blot strategies. In the human eye, OA1
was present on the apical cell surface of the retinal pigment
epithelial cells (RPE) in situ (Figure 1A). Quantiﬁcation of cell
surface, biotinylated OA1 in ﬁve human eyes indicated that at
least 3.5 6 0.7% of the total OA1 resided on the apical cell
surface of RPE in situ. Access to the biotinylation reagent
using eye cup preparations is restricted to the apical surface,
so the polarity of OA1 in the epithelium cannot be
determined. Further, the total cell surface OA1 is likely
underestimated because of the lack of access to the basal cell
surface. Blots were also probed with antibodies against actin
as a control to verify that cytoplasmic proteins were not
biotinylated, and in each experiment, actin was only found in
the unbound fraction.
Others have reported that recombinant OA1 and OA1-GFP
is almost exclusively localized to the endosomal compartment
in cultured cells [14,15,17,18,20–22]. However, when overex-
pressed [16], or when endocytosis is inhibited [17], OA1
accumulates at the cell surface. Our observation that OA1
protein is present on the apical surface of RPE in situ led us
to explore the issue further.
Effects of Tyrosine on OA1 Expression and Distribution
Endosomal localization of GPCRs occurs normally after
exposure to a ligand. Therefore, we investigated whether a
ligand for the receptor was present in the standard
incubation medium that could drive internalization of OA1.
Since the standard culture medium contains 500 lM tyrosine,
and tyrosine is the starting material for pigment synthesis, we
evaluated the effect of tyrosine on receptor distribution. To
test whether tyrosine affected OA1 distribution in cultured
cells, we formulated DMEM without tyrosine, and used
dialyzed fetal bovine serum. In the presence of tyrosine-free
medium, OA1 was detected on the plasma membrane of
cultured RPE cells both in the absence (unpublished data),
and in medium containing low concentrations of tyrosine (1
lM, Figure 1B). Averaged over ﬁve experiments, 4.5 6 1% of
total OA1 protein was observed on the surface of cultured
RPE maintained in 1 lM tyrosine, similar to what was
observed for RPE in situ. In all experiments, actin was
observed in the unbound protein fraction, demonstrating the
absence of any cytoplasmic protein in the cell surface assay.
Similarly, OA1-GFP expressed in COS cells illustrated a cell
surface expression that was tyrosine sensitive (Figure 1C).
Quantiﬁcation of six such experiments indicated signiﬁcant
variability in the amount of OA1 found at the cell surface
using transient transfections. The range of OA1 in the bound
fraction of transfected cells maintained in 1 lM tyrosine
ranged between 5%–40%, unlike the results with the
endogenous OA1 protein that were reproducibly approx-
imately 5%.
Not only was the distribution of OA1 in transfected cells
sensitive to tyrosine levels in the medium, but total OA1-GFP
expression was increased 5-fold in cells maintained in 1 lM
tyrosine. To verify that this difference related to OA1
expression rather than cell number, we evaluated actin
expression from the paired samples. The data (Figure 1D)
presented as optical density units indicate no difference in
actin. We also compared the amount of cell surface OA1
between the normal and low-tyrosine groups. Importantly, in
the ﬁve RPE experiments and six OA1-GFP in COS experi-
ments, we were unable to reproducibly detect OA1 in the
plasma membrane fraction of cells in standard medium,
similar to that found by others.
The distribution of OA1 in RPE cells also was evaluated by
confocal microscopy. OA1 has previously been characterized
as an endosomal protein in cultured RPE cells as shown in
Figure 1E. In contrast, the distribution of OA1 in low-tyrosine
medium was diffuse on the plasma membrane of cultured
RPE cells, with little endosomal accumulation (Figure 1F), an
observation consistent with the results obtained using
biochemical methods.
L-DOPA as a Natural Agonist for OA1
Tyrosinase function in melanogenesis begins with its
activity on tyrosine to create L-DOPA, followed by a second
reaction to create dopaquinone that leads to pigment
formation [25]. Of the intermediates between tyrosine and
melanin, L-DOPA has the greatest half-life, and L-DOPA is
released into the subretinal space apical to the RPE when
melanin synthesis occurs [23,24]. L-DOPA is also the
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Author Summary
Albinism is the loss of pigmentation caused by mutations in one of
several different genes that alter pigment synthesis by different
mechanisms. In the eye, albinism impairs sensory retina develop-
ment and causes significant vision problems. Regardless of the
genetic mutation that causes albinism, the associated vision
problems are the same. Interestingly, none of the pigmentation
genes are expressed by the sensory retinal cells affected by albinism
but by neighboring, retinal pigment epithelial cells (RPE). Further-
more, loss of pigmentation in RPE somehow leads to imprecise
retinal development. To investigate this cellular relationship, we
studied OA1, which is encoded by a gene in which mutations cause
ocular albinism. OA1 is unique among proteins involved with
albinism because OA1 is a potential receptor that could participate
in signal transduction rather than being a direct member of the
pigment synthesis machinery. We show that the ligand for OA1 is L-
DOPA, thus removing OA1 from orphan G-protein coupled receptor
(GPCR) status. L-DOPA is a by-product of pigment synthesis,
indicating that pigment synthesis and OA1 signaling are inter-
twined. OA1 signaling is highly selective for L-DOPA, and we show
that two closely related molecules, dopamine and tyrosine, bind to
OA1 but fail to stimulate signaling. We also show that OA1 signaling
controls secretion of a potent neuron survival factor. Taken
together, our data suggest that all forms of albinism produce the
same retinal defects because of a final common pathway through
OA1 signaling with downstream effects on RPE neurotrophic factor
secretion.precursor to dopamine, a neurotransmitter produced by
dopaneurgic neurons from tyrosine. The release of calcium
from intracellular stores is a common downstream effect of
GPCR activation by a ligand. Since the expression of OA1 on
the cell surface appears to be sensitive to tyrosine, we
examined whether tyrosine, or its metabolites L-DOPA and
dopamine, could stimulate inﬂux of Ca
2þ into the cytoplasm
in an OA1-dependent manner. CHO cells were transfected
with an OA1 expression vector then maintained in DMEM
containing 1 lM tyrosine for 48 h, followed by tyrosine-free
DMEM for 24 h to facilitate cell surface expression of OA1.
Intracellular Ca
2þ was evaluated using Fura-2, and [Ca
2þ]i was
determined by ratiometric imaging [26]. In the absence of any
ligand, [Ca
2þ]i was not signiﬁcantly different between trans-
fected and untransfected cells (Figure 2). Tyrosine and several
tyrosine metabolites were tested at 1 lM for an effect on
[Ca
2þ]i. As a positive control, we ended each experiment by
treatment with 20 mM KCl to depolarize the cell and increase
[Ca
2þ]i via activation of voltage-gated channels. This maneu-
ver served to verify the Fura-2 loading and responsiveness of
the cells being tested (Figure 2). Only L-DOPA elicited a
signiﬁcant increase in [Ca
2þ]i (Figure 2A). Tyrosine and
dopamine had no positive effect on intracellular at [Ca
2þ]i
concentrations up to 1 mM (unpublished data). The slight
negative effect of 1 lM dopamine was not statistically
signiﬁcant, but it was reproducible among the 11 experiments
with dopamine (Figure 2B).
Overexpression of GPCRs in nonnative cell lines can lead
to false signal transduction coupling. To verify that OA1
signaling in response to L-DOPA was indeed a natural
Figure 1. Cell Surface OA1
(A–C) Western blot analysis of proteins bound (B) or unbound (U) to strepavidin-conjugated beads after biotinylation of RPE in situ, cultured RPE (B),o r
COS cells transfected to express OA1-GFP (C). Blots were probed to visualize OA1 and actin after cell surface biotinylation and fractionation using
strepavidin-conjugated beads. For cultured cells (B and C), cells were either maintained in 500 lM (normal DMEM) or 1 lM tyrosine for 3 d prior to
analysis.
(D) Quantification of western blot analysis by densitometry. OA1 densitometry is shown as the percentage of the control for paired cell cultures,
transfected, and then split into two equal groups, one of which was the control, maintained in normal DMEM (control; open bars). The other group was
maintained in 1 lM tyrosine DMEM (LT; solid bars) until harvest. Paired t-test analysis was used to test whether the difference was significant, and an
asterisk (*) denotes p , 0.001. Actin, analyzed the same way, showed no differences, and p ¼ 0.724.
(E and F) Composite confocal microscopy of pigmenting RPE cells maintained in normal DMEM (E) or 1 lM tyrosine (F), and then stained with anti-OA1
antibodies and imaged at 203. Bar represents 25 lm.
doi:10.1371/journal.pbio.0060236.g001
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L-DOPA Is an Endogenous Ligand for OA1response, we expressed OA1 in RPE cells (Figure 2C). Results
using transfected RPE cells were similar to those achieved
with transfected CHO cells. RPE cells transfected to express
OA1 responded to 1.0 lM L-DOPA with an increase in [Ca
2þ]i.
We next sought to determine whether RPE cells expressing
the endogenous OA1 receptor, at endogenous levels ex-
hibited L-DOPA responsiveness. Like all of the transfected
cell experiments, RPE expressing OA1 demonstrated an
increase in [Ca
2þ]i after treatment with 1.0 lM L-DOPA
(Figure 2C).
To further characterize OA1 signaling activity, we used
pertussis toxin to distinguish between Gq coupled [Ca
2þ]i
signaling and Gi linked signaling (Figure 2C). In all cells
studied, pertussis toxin lowered the basal level of [Ca
2þ]i,
indicating its activity on inhibition of the background
signaling through Gi subunit activity. Pertussis toxin was
used in experiments conducted in cells transfected to express
OA1 including both CHO and RPE, as well as RPE expressing
the endogenous OA1 protein at natural levels. In all trans-
fected cells tested, the measured [Ca
2þ]i response to L-DOPA
was greater than in the absence of the toxin (Figure 2), owing
largely to the lower initial [Ca
2þ]i. Thus, the signaling through
OA1 in response to L-DOPA that results in increase [Ca
2þ]i is
not pertussis toxin sensitive and likely Gq subunit mediated.
We also measured the second messenger cAMP in CHO cells
transfected to express OA1 (Figure 2D). Using inactive cells
or a submaximal forskolin treatment, the experiments were
set up to measure either an increase or decrease in cAMP in
response to L-DOPA. In six such experiments, no change in
cAMP was observed suggesting neither Gs nor Gi subunits are
involved in OA1 signaling.
We utilized standard methods of radiolabeled ligand
binding to characterize the interaction between OA1 and L-
DOPA (Figure 3A). CHO cells were transfected to express
OA1, then binding of L-DOPA was quantiﬁed in a concen-
tration-dependent manner, and the results were further
characterized by Scatchard plot analysis (Figure 3A, inset).
Results illustrate saturable binding of L-DOPA to OA1
expressing cells with a Kd of 9.35 3 10
 6 M. No speciﬁc
binding was observed in untransfected CHO cells, indicating
that the cells do not have an endogenous L-DOPA receptor
(unpublished data). All binding parameters, total, speciﬁc,
and nonspeciﬁc, are shown as supplemental data (Figure
S1A). Tyrosine exhibited the potential to interact with OA1,
but neither tyrosine nor dopamine stimulated OA1 signaling
(see Figure 2). We next used competitive ligand binding to
determine whether either tyrosine or dopamine competed
with L-DOPA for OA1 binding. At high concentrations (1
mM), both tyrosine and dopamine competed with L-DOPA
for OA1 binding (Figure 3B). To further characterize this, we
Figure 2. Increased Intracellular Calcium in Response to L-DOPA.
(A) Representative traces of [Ca
2þ]i during the time course of the standard experimental protocol in transfected and untransfected CHO cells. After
establishment of a stable baseline for 3 min, the test agent was added at 1 lM. At 5 min, KCl was added to serve as a control that the cells were Fura-2
loaded and patent. Identical protocols were performed for both transfected cells and paired untransfected cells.
(B) Summary data for [Ca
2þ]i in response to tyrosine, dopamine, and L-DOPA in transfected and untransfected CHO cells. Untransfected cells are shown
with L-DOPA treatment. Our experimental control of membrane depolarization with KCl is also shown. Each bar represents data collected from at least
ten experiments and is presented as the mean change from baseline [Ca
2þ]i after test agent addition. Error bars represent SD, t-test analyses were used
to test for significant differences, and an asterisk (*) denotes p , 0.01.
(C) Analysis of pertussis toxin sensitivity of [Ca
2þ]i increase in cells transfected to express OA1 or RPE that express the natural protein. Data represent
mean of at least six experiments for each group of transfected cells and 20 individual experiments for each of the treated and untreated RPE with
endogenous OA1 expression. The t-test analyses were used to test for significant differences, and an asterisk (*) denotes p , 0.01.
(D) cAMP was measured in CHO transfected to express OA1. The control group represents transfected, but untreated, CHO cells and the basal level of
cAMP in those cells. Cells were treated with 1.0 lM L-DOPA, 0.1 lM forskolin, L-DOPAþ0.1 lM forskolin, and as a positive control, 1 lM forskolin. Results
represent the mean cAMP levels observed in at least six experiments in which all experimental groups were analyzed in a paired fashion using replicate
monolayers in the same culture plate. Error bars represent the SD of each group, and the only significant difference observed was the increase in cAMP
levels after forskolin treatment.
doi:10.1371/journal.pbio.0060236.g002
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L-DOPA Is an Endogenous Ligand for OA1examined the kinetics of the competition between L-DOPA
and either dopamine (Figure 3C) or tyrosine (Figure S1B).
Dopamine exhibited competitive binding to a single site with
L-DOPA with a Ki of 2.33 3 10
 6 6 0.2 3 10
 6 M. Similar
experiments with tyrosine demonstrated inhibition of L-
DOPA binding only at high concentrations (Figure S1B).
Saturation kinetics were not possible with tyrosine because of
its low afﬁnity and insolubility at the high concentrations.
Given the relatively low afﬁnity of OA1 for L-DOPA, we
sought to determine whether its signaling activity was dose
dependent in the range of this binding afﬁnity. We tested the
concentrations in which binding data suggested the steepest
rise in association between L-DOPA and OA1, 1.0–10 lM, and
results illustrate a concentration-dependent GPCR response
as measured by [Ca
2þ]i (Figure 3C). Thus, the activation
kinetics of L-DOPA and OA1 matched the concentration
range observed in radiolabeled ligand binding experiments.
In response to ligand binding, GPCRs recruit b-arrestin to
the plasma membrane, which is followed by internalization of
the ligand–receptor complex [27–33]. We next sought to test
the effect of L-DOPA on b-arrestin localization (Figure 4).
Cells were transfected to express OA1 and then cultured in 1
lM tyrosine DMEM for 48 h prior to analysis to allow cell
surface expression of the protein. Cells were then treated
with 1 lM L-DOPA, followed by rapid ﬁxation on ice in cold
methanol. Initially, under resting conditions in the absence of
an agonist, OA1-GFP was found at the cell surface and b-
arrestin was diffuse in the cytoplasm (Figure 4A–4C), with no
colocalization between the proteins. After stimulation with L-
DOPA, OA1 and b-arrestin were colocalized at the plasma
membrane (Figure 4D–4F). Untransfected cells showed no
response to L-DOPA treatment (Figure 4G and 4H), illustrat-
ing that the L-DOPA effect on b-arrestin distribution was
OA1 dependent, similar to results obtained for [Ca
2þ]i.
Effects of 1-DOPA on PEDF Secretion
Mutations in OA1 cause defects in the development of the
neurosensory retina. In previous work, we have shown that
pigmented RPE secrete signiﬁcantly more PEDF than non-
pigmented RPE [34], and PEDF is a neurotrophic factor with
the potential of altering neurosensory retina development
[35–41]. Mutations in OA1 cause a loss of pigmentation in the
RPE, suggesting that OA1 activity governs RPE pigmentation.
Thus, we sought to determine whether L-DOPA stimulation of
pigmented RPE cells caused increased secretion of PEDF
(Figure 5). This assay is made somewhat more difﬁcult
because pigmenting RPE cells produce L-DOPA, which is
the agonist for OA1, and OA1 is not readily detectable in
nonpigmented cultures of RPE. Thus, we used pigmented RPE
to determine whether L-DOPA stimulation increases PEDF
expression/secretion. RPE cells were placed in tyrosine-free
medium for 24 h and then treated with 1 lM L-DOPA for 1 h.
After treatment, the cells were returned to standard medium
Figure 3. OA1 Ligand Binding
(A) Binding kinetics between OA1 and L-DOPA were determined using radiolabeled ligand binding assays. Results represent data collected from five
such experiments and are presented as mean specific binding 6 SEM. The hyperbolic curve fit exhibited an r
2 value of 0.994, Kd was determined to be
9.34 3 10
 6 M 6 1.14 3 10
 6 M. The inset Scatchard plot illustrates the kinetics of a single-site binding relationship.
(B) We examined the comparative binding of 5 lM[ H
3] L-DOPA to OA1-transfected CHO cells in the presence of 1.0 mM dopamine, tyrosine, or L-DOPA.
The data represent mean total binding 6 SD for each group. An asterisk (*) denotes p , 0.05 when comparing the results between the control group to
the binding in the presence of the potential competitive ligands.
(C) Competitive interaction between 5 lM[ H
3] L-DOPA and dopamine was assessed to determine whether dopamine functions as an antagonist of OA1
activity. Results indicate that dopamine and L-DOPA compete for the same OA1 binding site, and the data fit the binding model with an r
2 value of 0.95.
The Ki for dopamine was 2.388 6 0.266 lM (mean 6 SEM), similar to the Kd for L-DOPA.
(D) Dose-dependent OA1 signaling through OA1. Data represent mean increase in [Ca
2þ]i elicited by L-DOPA treatment of the cells at the concentrations
given (n¼6 for each dose). We used t-test analyses to compare between the responses achieved at each dose, and an asterisk (*) denotes p , 0.01 for
the comparison at 1 and 10 lM.
doi:10.1371/journal.pbio.0060236.g003
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L-DOPA Is an Endogenous Ligand for OA1without exogenous L-DOPA for 3 d. Control cells were not
treated with L-DOPA, but the medium was changed at the
same time the experimental cells were returned to normal
medium. Conditioned medium was collected after 3 d, and
PEDF was measured. Results illustrate a signiﬁcant increase in
the secretion of PEDF in pigmented cells treated with L-
DOPA when compared to paired, control monolayers of
pigmented RPE (Figure 5A). Importantly, this signiﬁcant
increase occurred in cells that were pigmenting and therefore
expressed OA1 and had a basal level of PEDF expression.
To determine whether pigmented RPE cells secrete PEDF
through an autocrine loop involving tyrosinase activity and
OA1 signaling, we used a speciﬁc tyrosinase inhibitor
phenylthiourea (PTU) to inhibit pigmentation and L-DOPA
production (Figure 5B). In these experiments, pigmented RPE
cells were either maintained in DMEM, or DMEM containing
200 lM PTU, for 3 d, then PEDF secretion was measured.
Pigmented RPE secreted substantial PEDF, but PTU caused a
signiﬁcant decrease in PEDF secretion, indicating that
tyrosinase activity is necessary for the high level of PEDF
secretion observed in pigmented RPE cells. To verify that it
was the lack of L-DOPA in the PTU-treated cells that caused
the decreased PEDF secretion, we used three different
cultures of pigmented RPE and exposed them to PTU for
48 h, then treated them with 1.0 lM L-DOPA in the continued
presence of PTU and measured PEDF after 72 h (Figure 5C).
The data are presented as percent of control for this
experiment because the cultures used varied in both
pigmentation and PEDF expression before the experiment
began. PTU-treated RPE responded to the added L-DOPA by
increasing PEDF secretion, indicating that the effect of PTU
on PEDF secretion is caused be the lack of L-DOPA
production when tyrosinase is inhibited.
Discussion
There is a complex intertissue relationship between the
RPE and the neurosensory retina. One aspect of this
relationship is centered on RPE pigmentation, and defects
in melanin synthesis that result in signiﬁcant neurosensory
retina alterations [8,23,42]. Our data suggest that OA1 and
tyrosinase participate in an autocrine loop through L-DOPA
that regulates the secretion of at least one potent neuro-
trophic factor, PEDF. We also suggest that the pathologic
changes in retinal development that occur in albinism may
result from changes in the activity of the OA1 signaling
pathway. Reduced OA1 signaling activity can be caused either
directly through OA1 mutations or indirectly through
changes in L-DOPA production by tyrosinase activity. Thus,
we hypothesize that the similar retinal phenotypes that
accompany the diverse forms of albinism can be reconciled
to a single common pathway, OA1 signaling.
In our study, we observed OA1 on the apical surface of
human RPE in situ. Previous reports have suggested that OA1
in mice is localized to the melanosome [22], and in cultured
cells to the endosomal compartment [15–18,20–22,43]. Our
results from in situ RPE preparations indicate that OA1 is
distributed to the apical surface of the RPE. The limited
quantities of OA1 on the surface of the RPE (;3.5% of total
OA1) may account for the lack of observation of the protein
in previous studies in which immunogold electron micro-
scopy was used. Like many cell surface GPCRs, OA1 is not an
abundant protein.
The endosomal localization of OA1 reported in previous
studies using cultured cells was reproduced in this study for
both the endogenous protein and the transgenic protein.
When it was tested in normal culture medium, we found little
detectable OA1 protein on the cell surface, in agreement with
all previous work. However, reduction of tyrosine in the
medium caused a modest increase in cell surface receptor
accumulation of both the endogenous and recombinant OA1
proteins. This suggests that the distribution of OA1 to the cell
surface in cultured cells is sensitive to tyrosine. A previous
study has demonstrated OA1 could be localized to the cell
surface when endocytosis is inhibited [17], and we observed
OA1 on the apical surface of human RPE in situ. We suggest
OA1 is a cell surface GPCR, but is a target for endocytosis
that may be stimulated by tyrosine or tyrosine metabolites. In
this regard, our results differ from past reports of OA1
localization that have classiﬁed OA1 as a unique type of
intracellular GPCR. Most GPCRs are cell surface proteins that
are internalized by a variety of signals, and our data suggest
OA1 is similar to most other GPCRs.
OA1 signaling activity was stimulated by L-DOPA, but not
by either its precursor, tyrosine, or its neuronal metabolite
Figure 4. Ligand-Dependent Recruitment of b-arrestin to OA1
(A–F) All images represent 2-lm-thick confocal sections of CHO cells
transfected to express OA1-GFP (green). b-arrestin was visualized using
immunofluorescence methods (red) prior to addition of L-DOPA (A–C)
and after treatment with 1 lM L-DOPA (D–F), and the merged images (C
and F) illustrate regions where the two proteins colocalize, at the
resolution of white light imaging. Bar represents 10 lm.
(G and H) are low magnification of field images of transfected CHO cells,
with two transfected cells visible (arrows) (G). The remainder of the cell
population is visualized using antibodies to b-arrestin (H) to illustrate
that b-arrestin recruitment to the membrane only occurred in the OA1-
expressing cells (arrows). Bar represents 25 lm.
doi:10.1371/journal.pbio.0060236.g004
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L-DOPA Is an Endogenous Ligand for OA1dopamine. This result suggests an exquisitely sensitive
receptor activity able to distinguish between closely related
molecules; after all, L-DOPA and tyrosine differ by a sole
hydroxyl group. OA1 is sensitive to tyrosine, as tyrosine
causes an intracellular localization of OA1 in cultured cells.
However, we noted no signaling response to tyrosine, and
competition binding studies suggest that tyrosine has a low
afﬁnity for OA1. Our data suggest that the continuous
exposure of cells to high concentrations of tyrosine present
in normal medium is sufﬁcient to result in internalization of
OA1, but it is unlikely to result in measurable OA1 activation.
We found strong evidence of a single-site competitive
interaction between L-DOPA and dopamine. The Ki observed
for dopamine was similar to the Kd observed for L-DOPA,
suggesting that the afﬁnity for the two tyrosine metabolites is
similar. Our results illustrated a slight, but reproducible,
decrease in OA1 signaling from dopamine, suggesting that
dopamine may be an effective antagonist or inverse agonist
for OA1.
As an orphan GPCR, its signaling pathway has not
previously been identiﬁed. In this study, we illustrate that
OA1 signaling in response to L-DOPA causes an increase in
[Ca
2þ]i. Our data illustrate that the increased [Ca
2þ]i observed
in response to L-DOPA was insensitive to pertussis toxin, and
we measured no effects on cAMP, indicating that OA1 is
likely signaling through a Gq subunit. Previous work has
suggested that OA1 can associate with multiple subunits in
transfected cells, including members of the Go,G i, and Gq
subunit families. Innamorati et al. has shown that sponta-
neous activity of overexpressed OA1 is likely signaled through
a Gq subunit [16]. Our data indicate that ligand-dependent
signaling from endogenous OA1 in RPE most likely occurs
through a Gq-mediated pathway, and we observed no
promiscuous coupling activities when comparing OA1 over-
expression in CHO and RPE to natural OA1 expressed in
RPE. Interestingly, two overactive mutant forms of Gq
subunits cause hyperpigmentation in skin and hair [44], but
whether they have an effect in RPE is unknown. RPE and
cutaneous melanocytes use the same enzymes to produce
pigmentation but differ in their control of melanogenesis. A
recent report suggests that OA1 may signal through Gai3,
because the retinal phenotype of OA1
 /  and Gai3
 /  are
similar [45]. That study provided no data regarding inter-
action or signaling between Gai3 and OA1, and our results do
not support OA1 signaling through Gai3. However, both OA1
and Gai3 could have activity in convergent pathways that
govern some part of the complex system of retinal develop-
ment.
The response of OA1 to L-DOPA was measured in three
ways, increased [Ca
2þ]i, recruitment of b-arrestin to plasma
membrane OA1, and the increased secretion of PEDF. In
addition, we have inhibited the activity of tyrosinase in
pigmented RPE, which inhibits L-DOPA production and
observed a decreased secretion of PEDF. Taken together,
these studies present a strong argument for a productive
ligand:receptor relationship between L-DOPA and OA1.
Further, our data suggest selectivity among tyrosine and its
metabolites, with only L-DOPA being a productive ligand for
OA1. We have determined the binding kinetics between OA1
and L-DOPA, and observed a typical one-site receptor:ligand
relationship between the two. The binding afﬁnity between
OA1 and L-DOPA, with a Kd in the micromolar range, is not
uncommon for an endogenous ligand:receptor relationship.
Future identiﬁcation of a speciﬁc, high-afﬁnity antagonist for
OA1 will aid in further biochemical characterization of the
interaction between OA1 and L-DOPA, and be useful in
determining whether dopamine is an inverse agonist.
Figure 5. L-DOPA Stimulates PEDF Production in RPE
(A) PEDF concentrations were determined by ELISA of cell-conditioned
medium. RPE cells were control cells that were without L-DOPA
treatment (open bar), or OA1-stimulated cells that were treated with 1
lM L-DOPA prior to being maintained for 3 d in normal DMEM (solid bar).
Data are presented as the mean of three experiments conducted in
triplicate, error bars represent SD, and an asterisk (*) denotes p , 0.01
using a paired t-test.
(B) PEDF concentrations in conditioned medium from pigmenting RPE
determined by ELISA. Cells were either control pigmenting RPE cultures
(open bar) or paired cultures treated with phenylthiourea (PTU) at 200
lM (solid bar). Data are presented as the mean of three experiments
conducted in triplicate, error bars represent SD, and an asterisk (*)
denotes p , 0.01 using a paired t-test.
(C) PEDF concentrations in conditioned medium of pigmented RPE cells
treated with PTU and then treated with L-DOPA to stimulate OA1
signaling. ELISA assays were conducted prior to PTU treatment (open
bar), then after PTU treatment (solid bar), and then from the same
cultures after L-DOPA stimulation (checkered bar). Results are presented
as mean 6 SD of the value achieved related to that culture of cells. An
asterisk (*) denotes p , 0.01 when comparing PTU to the control (same
culture tested prior to PTU), and L-DOPA/PTU compared to the PTU
sample from that same culture.
doi:10.1371/journal.pbio.0060236.g005
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L-DOPA Is an Endogenous Ligand for OA1We have illustrated the selective activation of OA1, an
orphan GPCR, by L-DOPA, an intermediate product of
melanin synthesis. We have also illustrated that OA1 activity
stimulates PEDF secretion by RPE, a molecule that has the
potential to support normal retinal development [40,41]. In
humans, this suggests that pharmacologic intervention
through OA1 activation could be useful for albinism caused
by defects in the melanogenic machinery (OCA 1–4).
Unfortunately, our data also suggest that OA1 is necessary
for such pharmacologic intervention, and mutations in Oa1
are the most common cause of albinism.
Materials and Methods
Cell culture. RPE were isolated as described [46] and maintained in
Dulbecco’s modiﬁed essential medium (DMEM) supplemented with
5% fetal bovine serum (FBS). For experiments in which tyrosine
concentrations were lowered, we used custom manufactured DMEM
produced without tyrosine by JRH Biosciences. Dialyzed FBS was
purchased from Invitrogen.
COS-7 and CHO cells were obtained from ATCC and cultured in
DMEM supplemented with 5% FBS. For analysis of OA1 distribution,
cells were cultured in tyrosine-free DMEM supplemented with 1 lM
tyrosine, 5% dialyzed FBS for 2–4 d, then tyrosine-free medium as
described for the experiment.
Cell surface biotinylation. Human RPE in situ. Human eyecups were
produced by dissection approximately 2 mm anterior to the equator
and removal of the anterior segment. The vitreous and retina were
removed without impairing the underlying RPE monolayer, and the
retina was cut at the optic nerve head. The resulting eyecups with
RPE exposed were rinsed three times with reaction buffer (100 mM
NaCl, 50 mM NaHCO3 [pH 8.0]) and then ﬁlled with Sulfo-NHS-LC-
Biotin (1 mg/ml) two times for 30 min. The reaction was stopped with
TG buffer (25 mM Tris, 192 mM glycine [pH 8.3]) and then the cells
were harvested in lysis buffer (2 mM EDTA, 1% Triton X, and 1%
Tween 20 in Tris Base Saline Buffer) containing Halt Protease
Inhibitor Cocktail. Intact cells and pigment granules were removed
by centrifugation at 14,000 rpm for 20 min. Biotinylated proteins
were captured overnight with immobilized streptavidin beads and
then mixed with 43 reducing buffer (250 mM Tris [pH 6.8], 8% SDS,
40% glycerol, 20% beta-mercaptoethanol, 0.08% bromophenol blue).
The OA1 protein was separated on a 10% SDS-PAGE gel and
identiﬁed by a using a polyclonal rabbit OA1 antibody for western
blot analysis. Paired western blots were probed with a monoclonal
antibody directed against actin.
Cultured cells. RPE and transfected cells were maintained in DMEM
containing tyrosine concentrations described for the experiment.
Cultures were rinsed three times in reaction buffer, then biotinylated
as described above for the in situ preparation.
Cloning of Oa1. A cDNA library was constructed from pooled
tissue from six human donor eyes. Total RNA was harvested using
Trizol reagent, then cDNA was synthesized using Poly-T primers for
the ﬁrst-strand synthesis, and random hexamers for the second
strand. Following cDNA synthesis, RNA was removed using RNase A.
The coding sequence for OA1 was obtained by PCR using terminal
primers that added restriction sites to the 59 and 39 ends and
removed the native stop codon. The PCR product was ligated in
frame with GFP in the pEGFP N-1 vector (Clontech). The sequence
was veriﬁed by automated sequencing in both directions over the
entire sequence.
Immunocytochemistry. Cells on slides were ﬁxed with 3%
paraformaldehyde at room temperature, rinsed with 0.1% Triton
X-100 in 10% milk in TBST, and then blocked with 10% milk in
TBST. b-arrestin was visualized using a polyclonal antibody directed
against b-arrestin, and incubated overnight at 4 8C. Cover slips were
mounted using 50% glycerol, and immunostaining was analyzed by
optical sectioning using a Nikon Eclipse E800 laser scanning
confocal microscope powered by Compix Confocal Imaging Systems
software (Simple PCI Version 4.0.6.1605). Three-dimensional analysis
of OA1-GFP and b-arrestin distribution was performed in ImageJ
1.32.
Measurement of [Ca
2þ]i. OA1-GFP expressing CHO cells plated on
glass cover slips were rinsed in Ca
2þ-containing HEPES-buffered
Hanks Balanced Salt Solution (HBSS) (pH 7.45) and then incubated
with 2.5 lM Fura-2 (solubilized in anhydrous dimethylsulfoxide and
0.002% pluronic acid) for 20 min at 37 8C, 5% CO2.The Fura-2–
loaded cells were rinsed with HBSS for 15 min at 37 8C, 5% CO2 to
allow for full cleavage of the dye to its active form. Each cover slip was
incubated in 1 ml of HBSS in a chamber held at 37 8C on the stage of
an inverted Olympus IX70 microscope equipped with a 4031.35 NA
UV-ﬂuor objective.
Using a ﬁlter wheel, excitation light from a 200 W Xe bulb was
passed alternately through 340- and 380-nm ﬁlters. A 10-nm bandpass
ﬁlter, centered at 510 nm, selected for the emitted ﬂuorescence that
was passed to a CCD camera (Photometrics CH-250).
For each experiment, image pairs were taken every minute for the
ﬁrst 3 min, which established a stable baseline. L-DOPA (1 lM ﬁnal
concentration) was then added, and image sets were taken every 30 s
for the next 3 min. Finally, KCl (20 mM ﬁnal concentration) was
added 1 min before completion of each experiment as a positive
control to establish that the cells were loaded with Fura-2. The same
was repeated independently for tyrosine and dopamine (both at 1 lM
ﬁnal concentration).
Using a Silicon Graphics Personal IRIS computer, the 340/380-nm
ratio was computed for each pixel within a cell, and then analyzed
using Microsoft Excel version 4.0 (Microsoft). Once the 340/380-nm
ratio was determined, each ratio was normalized to 1 (ratio at time
zero divided by itself), and then the free ion concentration was
calculated using the following equation:
½Cai # ¼ Kd# ðR   Rmin#Þ=Rmax#   RÞð 1Þ
in which R, Rmin, and Rmax are the measured, minimum, and
maximum ratios, respectively. Rmax represents the ratio of ﬂuores-
cence intensity of ion-sensitive wavelengths under fully deprotonated
conditions, whereas Rmin is the ratio for the dye when it is fully
protonated. In the case of Fura-2, R increases with increasing Ca
2þ;
hence Rmin represents Fura-2 in the absence of Ca
2þ (Ca
2þ , 1 nM),
whereas Rmax represents the Ca
2þ-Fura-2 chelate as previously
described [26]. Rmin, Rmax, and Kd were determined in independent
experiments in Fura-2–loaded cells, and subsequently utilized for
calculation of free Ca
2þ for the experimental procedures.
Radiolabeled ligand binding. CHO cells that were transfected to
express OA1-GFP were plated into 24-well plates. Cells were chilled
to  2 8C, then rinsed in cold binding buffer, 25 mM Tris, 150 mM
NaCl, 5 mM EDTA, 5 lM digitonin (pH 7.45). Cells were incubated for
2 h in binding buffer containing [
3H]-L-DOPA (Moravek Biochem-
icals) at concentrations between 10
 4 Mt o1 0
 9 M. The temperature
was not allowed to exceed  2 8C at any step of the assay. Controls
included assays conducted on nontransfected CHO, and speciﬁc
binding was determined by competition with excess unlabelled L-
DOPA at 10
 3 M. Bound L-DOPA was quantiﬁed by scintillation
spectroscopy.
Measurement of cAMP. Cells were pretreated with forskolin (15
min) and then challenged with L-DOPA using an assay setup as
previously described [47]. After 1 min of ligand exposure, cells were
scraped into ice-cold buffer, boiled, and then centrifuged. Equivalent
volumes, 50 ll, of supernate and
3H-cAMP (New England Nuclear)
were then combined with 100 ll of cold PKA. After 2 h, the solution
was passed over activated charcoal, and supernates were counted in a
scintillation counter. Results were compared to those achieved using
a standard curve, instead of cytosol, produced using 50 ll of cAMP
0.25–32.0 pmol/50 ll.
Supporting Information
Figure S1. Supplemental Data
(A) Data represent mean 6 standard error of the mean (SEM) of
bound [3H]-L-DOPA in all fractions, total, speciﬁc, and nonspeciﬁc.
Nonspeciﬁc binding was determined by measuring radiolabeled-L-
DOPA bound in the presence of excess unlabeled L-DOPA (1 mM).
Speciﬁc binding at each given concentration is determined by
subtracting the measured nonspeciﬁc binding from the measured
total binding.
(B) The ﬁgure illustrates competitive interaction between tyrosine
and L-DOPA, measured using increasing concentrations of tyrosine
and 5 lM[ H
3] L-DOPA. Each data point represents the mean data
from ﬁve replicate wells, and the error bars represent standard
deviation (SD). Data illustrate that tyrosine competes for binding with
L-DOPA, but with a low afﬁnity. Our results suggest tyrosine has a Ki
of 52.9 lM, and ﬁts the single-site binding model with an r
2 value of
0.85. Saturation could not be achieved because of the limited
solubility of tyrosine.
Found at doi:10.1371/journal.pbio.0060236.sg001 (682 KB TIF).
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